Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity; D001201:Ascites / Q000188:drug therapy; D001769:Blood / Q000187:drug effects; D002277:Carcinoma / Q000188:drug therapy; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D046508:Culture Techniques; D006367:HeLa Cells / Q000187:drug effects; D007413:Intestinal Mucosa / Q000187:drug effects; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008198:Lymph Nodes / Q000187:drug effects; D008223:Lymphoma / Q000188:drug therapy; D051379:Mice; D008854:Microscopy, Electron; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011817:Rabbits; D051381:Rats; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D012510:Sarcoma 180 / Q000188:drug therapy; D012517:Sarcoma, Yoshida / Q000188:drug therapy; D013154:Spleen / Q000187:drug effects
D000970:Antineoplastic Agents